Login
Breast Cancer Research Review Issue 78, 2025
In this edition:
Potential of WGS data linked to mortality statistics in breast cancer Targeting dormant tumour cells to prevent recurrent breast cancer Patritumab deruxtecan in hormone receptor+, HER2− advanced breast cancer Weight loss intervention for women with stage II/III breast cancer ILD with trastuzumab deruxtecan in real-world advanced breast cancer Ki67 for predicting endocrine sensitivity in oestrogen receptor+, HER2– breast cancer Xentuzumab-abemaciclib-endocrine therapy in advanced breast cancer First-line zanidatamab-docetaxel in HER2-positive breast cancer FES- vs. FDG-PET-CT in oestrogen receptor+ metastatic invasive lobular breast cancer Acupuncture for hot flushes in breast cancer